Darmiyan Partners with CAHF to Enhance Cognitive Health Solutions
In a significant move for cognitive health, Darmiyan, Inc., a pioneering neurotechnology firm, has been named the exclusive Preferred Provider for Cognitive Health Solutions by the California Association of Health Facilities (CAHF). This association represents over 1,300 member facilities that collectively serve more than 350,000 residents throughout California. Such a collaboration opens doors for these facilities to access advanced tools that focus on early brain health evaluation and the prevention of dementia.
Introduction to BrainSee™
At the forefront of this partnership is BrainSee™, an innovative tool that is the only FDA-approved, AI-powered prognostic device specifically designed for assessing the risk of Alzheimer's progression within five years. This groundbreaking technology provides remarkable accuracy without needing any invasive methods. For CAHF members, having access to BrainSee™ means being equipped with the latest technology to address cognitive health proactively.
Benefits of Early Intervention in Dementia
One of the key advantages of BrainSee™ is its ability to identify individuals who are at an elevated risk of developing Alzheimer's, even when they have not yet been diagnosed with dementia. By detecting risk factors early, families can implement lifestyle changes, create proactive care plans, and embark on early intervention strategies aimed at preventing or delaying the onset of dementia. This delay offers families potentially another year of enhanced independence and quality of life. Moreover, each year that the onset of dementia is postponed can save payers approximately $50,000 per patient.
Leadership’s Vision for Better Brain Health
Expressing enthusiasm about this partnership, Dr. Padideh Kamali-Zare, CEO and Founder of Darmiyan, stated, "We are honored to join forces with CAHF, one of the nation's most respected state associations. Our aim is to transition brain health from reactive care to proactive prevention. This approach not only transforms residents' lives but also provides meaningful financial benefits to care providers. We are excited about what we can achieve together."
Echoing this sentiment, Cassie Dunham, CEO and President of CAHF, emphasized the importance of cognitive health in delivering high-quality, person-centered care. She noted that the collaboration represents a unique opportunity to enhance brain health and foster a sustainable impact across California. With the tools provided through Darmiyan, long-term care facilities can improve both their operational outcomes and the health of the residents they serve.
Empowering Care Providers with Predictive Tools
Integrating BrainSee™ into daily care practices allows CAHF members to gather early, objective, and actionable insights on residents' brain health. This integration facilitates timely interventions and aids care providers in utilizing resources more efficiently, ultimately enhancing residents' health and satisfaction. The collaboration sets a benchmark for improving brain health standards within long-term care, benefiting not only the residents but also their families.
About the California Association of Health Facilities (CAHF)
The California Association of Health Facilities (CAHF) is a non-profit trade organization representing various skilled-nursing and intermediate-care facilities for people with intellectual disabilities. The association is dedicated to ensuring quality care for vulnerable populations, including the elderly and those with chronic mental illnesses. CAHF's mission is centered around advocating for high standards of care and enhancing the well-being of its members and their residents.
About Darmiyan
Darmiyan was founded in 2016 and is headquartered in San Francisco. The company is dedicated to revolutionizing brain health management through its avant-garde, AI-enhanced platform, BrainSee™. With FDA approval and outstanding clinical accuracy, Darmiyan empowers healthcare providers to detect cognitive decline early and guide preventive measures, significantly improving patient outcomes.
Frequently Asked Questions
What is the focus of Darmiyan's collaboration with CAHF?
The partnership aims to enhance cognitive health solutions, providing advanced tools for early brain health assessment and dementia prevention.
What technology is being offered to CAHF members?
CAHF members will gain access to BrainSee™, the only FDA-approved tool for predicting Alzheimer's risk accurately.
How does early detection benefit patients and families?
Early detection allows for timely lifestyle changes and interventions, potentially delaying dementia onset and improving overall quality of life.
What is the mission of CAHF?
CAHF represents skilled nursing and intermediate care facilities, advocating for high-quality care for the frail elderly and those with disabilities.
What is unique about Darmiyan's BrainSee™ platform?
BrainSee™ is unique for its AI-driven, non-invasive approach to assessing the risk of dementia, enabling proactive health management.
